Relation of fibrin and tumour-associated antigens to the spread of ovarian cancer
暂无分享,去创建一个
O. Wilhelm | H. Graeff | R. Babic | R. Hafter | M. Röbl | R. Schröck | K. Jürgensmeyer
[1] H. Graeff,et al. Clinical aspects of fibrin formation and fibrinolysis measured with monoclonal antibodies against D-dimer , 1986 .
[2] D. Rylatt,et al. Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies. , 1984, Journal of clinical pathology.
[3] H. Graeff,et al. Crosslinked fibrin derivatives and fibronectin in ascitic fluid from patients with ovarian cancer compared to ascitic fluid in liver cirrhosis. , 1984, Thrombosis research.
[4] D. Rylatt,et al. An immunoassay for human D dimer using monoclonal antibodies. , 1983, Thrombosis research.
[5] J. Hanley,et al. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.
[6] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[7] R. Bast,et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. , 1981, The Journal of clinical investigation.
[8] J. Henderson,et al. Analysis of Twenty‐three Plasma Proteins in Ascites The Depletion of Fibrinogen and Plasminogen , 1980, Annals of surgery.
[9] M. Herlyn,et al. Colorectal carcinoma antigens detected by hybridoma antibodies , 1979, Somatic cell genetics.
[10] M. Scully,et al. A method for characterising serum fibrinogen and fibrin degradation products. , 1976, Thrombosis research.
[11] B. Åstedt,et al. Coagulative and fibrinolytic properties of ascitic fluid associated with ovarian tumors , 1975, Cancer.
[12] L. Sternberger,et al. THE UNLABELED ANTIBODY ENZYME METHOD OF IMMUNOHISTOCHEMISTRY PREPARATION AND PROPERTIES OF SOLUBLE ANTIGEN-ANTIBODY COMPLEX (HORSERADISH PEROXIDASE-ANTIHORSERADISH PEROXIDASE) AND ITS USE IN IDENTIFICATION OF SPIROCHETES , 1970, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[13] P. Gold,et al. SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM , 1965, The Journal of experimental medicine.
[14] H. Abe. [CLINICAL ASPECTS OF FIBRINOLYSIS]. , 1964, Nihon Ishikai zasshi. Journal of the Japan Medical Association.
[15] K. Ulm,et al. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer]. , 1986, Geburtshilfe und Frauenheilkunde.
[16] G. Markus. The Role of Hemostasis and Fibrinolysis in the Metastatic Spread of Cancer , 1984, Seminars in thrombosis and hemostasis.
[17] R. Bast,et al. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. , 1983, American journal of clinical pathology.
[18] H. Graeff,et al. Detection and Relevance of Crosslinked Fibrin Derivatives in Blood , 1982, Seminars in thrombosis and hemostasis.
[19] E. Engvall,et al. Fibronectin: purification, immunochemical properties, and biological activities. , 1982, Methods in enzymology.
[20] H. Graeff,et al. Subunit and macromolecular structure of circulating fibrin from obstetric patients with intravascular coagulation. , 1979, Thrombosis research.